Recurrent Hairy Cell Leukemia
7 clinical trials · Condition
◉ Watch Recurrent Hairy Cell Leukemia
| Record | Firm | Date |
|---|---|---|
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105) | City of Hope Medical Center | 2020-11-18 |
| CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma (NCT04578600) | Joseph Tuscano | 2020-10-23 |
| Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia (NCT02153580) | City of Hope Medical Center | 2014-09-24 |
| Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia (NCT01841723) | National Cancer Institute (NCI) | 2013-04-30 |
Track Recurrent Hairy Cell Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.